News and events
Introducing Dr Emmert Roberts
MARC's newest Clinical Research Fellow talks to MRC Insight about why he has chosen a career in Addiction.
Emmett will be undertaking an MARC funded PhD under the supervision of Professor Colin Drummond, and Prof Matthew Hotopf at King's College London. He will also be undertaking a fully funded MSc in Epidemiology prior to starting his PhD training.
PhD Opportunity December 2016
We’re pleased to announce an exciting PhD opportunity jointly supported by the NIHR Maudsley Biomedical Research Centre with research training provided by the new MRC Addictions Research Clinical Training Programme (MARC) at King’s College London under the supervision of MARC lead Collin Drummond. This post is available for up to 12-months full-time, but shorter-term and part-time posts are also options. The post is suitable for clinicians undertaking specialist training (ST3-5) and who have clinical experience of addictions and a desire to pursue an academic clinical career in this field including a PhD fellowship.
For more info please see the Job ad at https://www.hirewire.co.uk/HE/1061247/MS_JobDetails.aspx?JobID=74470
Application Deadline: Sunday 15th January 2017
PhD opportunities coming soon
A key vision of MARC is to promote opportunities for specialist addiction research, this includes funding for two PhD students at each participating university, Imperial College, King's College London and University Bristol.
The six selected researchers will have an opportunity to develop their research under the guidance and support of some of the country's leading specialists in addiction research.
We expect to announce our first call in early 2016. For initial enquiries please contact our administrator, Celeste Miles at email@example.com, or:
- Imperial College - Anne Lingford-Hughes (firstname.lastname@example.org)
- King's College London - Colin Drummond (email@example.com)
- University of Bristol - Matt Hickman (firstname.lastname@example.org
MARC PhD Call Out
We are pleased to announce that we are now taking applications for our MARC PhD clinical posts.
Applications are invited for this prestigious clinical PhD training programme in clinical addiction research to commence in the 2016-2017 academic year. Successful applicants are likely to be psychiatrists or psychologists however we welcome applications from other clinical specialities working in addiction e.g. public health, general practice. Support includes a clinical salary, PhD fees, research expenses, training funds, travel and meeting costs. The posts will be based at one of the MARC institutions.
Interested candidates are required to contact individual supervisors prior to submitting their application and should and will have included details of their research proposal on the application.
Further details can also be found on our PhD Call Out page. Closing date for applications is 19 September 2016.
*Please note this link may not work in Safari - please refer to the Imperial Website job pages reference HM2016106
MRC Summer School in Brain Disorders Research
We are pleased to announce that Marc lead Anne Lingford Hughes will be a speaker at the MRC Summer School in Brain Disorders Research.
This free four-day course hosted by the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University will cover topics including epidemiology, neuroimaging, molecular biology and genetics through lectures, interactive sessions and informal discussions.
The course will take place 11-14 July 2016 at the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University.
This Summer School aims to provide clinical trainees and non-clinical (MSc, PhD, first post-doc) scientists with a grounding in brain disorder research, and to inspire and inform the researchers of tomorrow.
A-Debate - U-Turn on Addictions (17th & 18th February)
In February ALICE RAP (Addiction and Lifestyles in Contemporary Europe Reframing Addictions Project) will be holding an exciting online and onsite debate on the concept, nature, consequences, business and governance of addictive products deriving from the ALICE RAP project.
Discussions will be stimulated by short scientific presentations on key topics - these will present the latest evidence and knowledge on drug use, harms and mechanisms and examine policy and programme options, prevention and treatment, to mitigate the harm caused by addictive products.
MARC's very own Anne Lingford-Hughes will be presenting at the event on "Dopamine and the failure of pharma treatment". Professor Lingford-Hughes will be among high-level scientists, policy actors from national and international organisations and expert civil society actors, and the debate is expected to shape the messages from multidisciplinary addiction science for drug policy influencers and implementers. A-Debate programme.
The event can be attended in person or online. The online A-Debate will be streamed live and can be viewed by anyone, without registration. Online participants can register to receive the draft A-Debate Science Summary Document and to actively participate actively (by sending comments and questions to the discussions). Register Here.
ALICE RAP is a European research project, co-financed by the European Commission, which started in April 2011 and aims to stimulate a broad and productive debate on science-based policy approaches to addictions. This will be an opportunity
We had a great day on the 3 December 2015 as the MRC Addiction Research Clinical Training (MARC) project was officially launched at The Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London.
The day was attended by over 60 addiction enthusiasts including members of the lead institutions, King's College London (IoPPN) Imperial College London, and University Bristol as well as health care professionals.
It was an opportunity to hear the goals and visions of the MARC as well as hearing from specialist researchers in the area including Dr Suzi Gage (speaking on 'Cannabis, tobacco and psychosis in ALSPAC' and Professor John Strang (speaking on 'Naloxone in the prevention of opioid death').
It was also our pleasure to welcome Professor van den Brink, University of Amsterdam, to complete the day speaking on his research into alcohol dependence and personalised treatment. Professor van den Brink is a world leading addiction psychiatrist and researcher. His research aims at uncovering neurobiological processes involved in the development of addictive behaviours.
The day also gave attendees the opportunity to network with other researchers and workers across the country with a specialist interest in addiction research.
It is hoped that this event marked the start of many opportunities to promote the work and vision of MARC.